Myasthenia gravis following iron chelation therapy with intravenous desferrioxamine.
Krishnan
K
K
Trobe
J D
JD
Adams
P T
PT
D000328:Adult; D000756:Anemia, Sideroblastic / Q000188:drug therapy; D003676:Deferoxamine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009157:Myasthenia Gravis / Q000139:chemically induced* / Q000188:drug therapy; D011729:Pyridostigmine Bromide / Q000627:therapeutic use
D003676:Deferoxamine; D011729:Pyridostigmine Bromide